Published in Ann Surg on April 01, 2017
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg (2004) 5.10
Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg (2004) 3.72
Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol (2006) 2.71
Liver resection for colorectal metastases: the third hepatectomy. Ann Surg (2003) 2.57
Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg (2006) 2.49
Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol (2008) 2.44
A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection. Gastroenterology (2013) 2.37
Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol (2009) 2.26
Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation. Transplantation (2002) 2.19
Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy? Ann Surg (2012) 2.18
Pulmonary complications after elective liver transplantation-incidence, risk factors, and outcome. Transplantation (2012) 2.11
Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg (2003) 2.02
Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. Gastroenterology (2012) 2.01
Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol (2011) 1.99
Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg (2013) 1.98
Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA (2008) 1.94
R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg (2008) 1.88
Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection. Ann Surg (2011) 1.83
A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg (2002) 1.78
Oncologic results of laparoscopic versus open hepatectomy for colorectal liver metastases in two specialized centers. Ann Surg (2009) 1.72
Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol (2008) 1.70
Immediate neuroendocrine signaling after partial hepatectomy through acute portal hyperpressure and cholestasis. J Hepatol (2010) 1.60
Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg (2008) 1.59
Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology (2008) 1.47
Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipients. J Hepatol (2011) 1.46
AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: By the AFC-IHCC-2009 study group. Cancer (2010) 1.44
The histologic pattern of "biliary tract pathology" is accurate for the diagnosis of biliary complications. Am J Surg Pathol (2005) 1.42
Donor age influences 10-year liver graft histology independently of hepatitis C virus infection. J Hepatol (2004) 1.41
Further details from the first human liver transplantation in Europe. Transplantation (2013) 1.39
Laparoscopic vs. open liver resection for hepatocellular carcinoma of cirrhotic liver: a case-control study. World J Surg (2014) 1.32
Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl (2007) 1.31
Portal vein arterialization: a salvage procedure for a totally de-arterialized liver. The Paul Brousse Hospital experience. HPB (Oxford) (2013) 1.27
Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol (2007) 1.23
Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication? HPB (Oxford) (2012) 1.17
Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation. Liver Transpl (2009) 1.15
Concomitant extrahepatic disease in patients with colorectal liver metastases: when is there a place for surgery? Ann Surg (2011) 1.12
Length analysis of polymerase chain reaction products: a sensitive and reliable technique for the detection of mutations in KIT exon 11 in gastrointestinal stromal tumors. Diagn Mol Pathol (2002) 1.11
Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes. J Am Coll Surg (2006) 1.10
Assessment of risk for non-hepatic surgery in cirrhotic patients. J Hepatol (2012) 1.09
Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation. Hepatology (2011) 1.08
When the Patient Is Sicker Than His Liver. Ann Surg (2015) 1.07
Liver Transplantation and Portal Vein Thrombosis: An Unfinished Saga. Ann Surg (2015) 1.06
Hepatocellular carcinoma: surgical indications and results. Crit Rev Oncol Hematol (2003) 1.05
Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray. Lab Invest (2006) 1.02
Therapeutic strategies in symptomatic portal biliopathy. Ann Surg (2007) 1.02
Longitudinal prospective evaluation of quality of life in adult patients before and one year after liver transplantation. Liver Transpl (2003) 1.00
The web-surfing bariatic patient: the role of the internet in the decision-making process. Obes Surg (2015) 1.00
Sarcopenia Impacts on Short- and Long-term Results of Hepatectomy for Hepatocellular Carcinoma. Ann Surg (2015) 1.00
A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients. Liver Transpl (2008) 0.99
Herpes simplex virus-associated acute liver failure: a difficult diagnosis with a poor prognosis. Liver Transpl (2005) 0.99
Management of excluded segmental bile duct leakage following liver resection. HPB (Oxford) (2009) 0.99
Ischemic preconditioning modulates the expression of several genes, leading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion. FASEB J (2005) 0.99
Outcome following hepatic resection of metastatic renal tumors: the Paul Brousse Hospital experience. HPB (Oxford) (2006) 0.98
ATP release after partial hepatectomy regulates liver regeneration in the rat. J Hepatol (2009) 0.98
Arantius' ligament approach to the left hepatic vein and to the common trunk. J Am Coll Surg (2002) 0.95
Going outdoors daily predicts long-term functional and health benefits among ambulatory older people. J Aging Health (2008) 0.95
Concurrent induction of necrosis, apoptosis, and autophagy in ischemic preconditioned human livers formerly treated by chemotherapy. J Hepatol (2009) 0.94
[Portal cavenorma: diagnosis, aetiologies and consequences]. Ann Chir (2002) 0.93
The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis. Carcinogenesis (2004) 0.92
Regenerative nodular hyperplasia of the liver related to chemotherapy: impact on outcome of liver surgery for colorectal metastases. Ann Surg Oncol (2010) 0.92
Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era. Clin Transplant (2013) 0.90
Real-time quantification of AFP mRNA to assess hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma. Ann Surg (2003) 0.90
Comparison between open and laparoscopic reversal of Hartmann's procedure for diverticulitis. World J Gastrointest Surg (2013) 0.87
Combination of topotecan and oxaliplatin in inoperable hepatocellular cancer patients. Am J Clin Oncol (2002) 0.87
Natural History of Adjustable Gastric Banding: Lifespan and Revisional Rate: A Nationwide Study on Administrative Data on 53,000 Patients. Ann Surg (2017) 0.86
Laparoscopic versus open resection for colorectal liver metastases: a single-center study with propensity score analysis. J Laparoendosc Adv Surg Tech A (2014) 0.86
Hepatic resection after down-staging of unresectable hepatic colorectal metastases. Surg Oncol Clin N Am (2003) 0.85
Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery. Obes Surg (2015) 0.84
Infusion of CD133+ Bone Marrow-derived Stem Cell After Selective Portal Vein Embolization Enhances Functional Hepatic Reserves After Extended Right Hepatectomy. Ann Surg (2016) 0.84
Tumour progression and liver regeneration--insights from animal models. Nat Rev Gastroenterol Hepatol (2013) 0.84
Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation. Liver Transpl (2011) 0.84
Early and Long-term Oncological Outcomes After Laparoscopic Resection for Colorectal Liver Metastases: A Propensity Score-based Analysis. Ann Surg (2015) 0.84
Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients. J Hepatol (2005) 0.83
Aspirin prophylaxis and the prevalence of anaemia. Age Ageing (2006) 0.83
[Inflammatory pseudotumor of the liver: a case of recurrence after resection]. Acta Gastroenterol Latinoam (2013) 0.83
Long-term outcomes after hepatic resection for colorectal metastases in young patients. Cancer (2010) 0.83
Liver resection for colorectal liver metastases with peri-operative chemotherapy: oncological results of R1 resections. HPB (Oxford) (2012) 0.83
Open and laparoscopic resection of hepatocellular adenoma: trends over 23 years at a specialist hepatobiliary unit. HPB (Oxford) (2014) 0.82
Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation. Liver Transpl (2010) 0.82
Interest of preoperative immunonutrition in liver resection for cancer: study protocol of the PROPILS trial, a multicenter randomized controlled phase IV trial. BMC Cancer (2014) 0.82
Caval inflow to the graft for liver transplantation in patients with diffuse portal vein thrombosis: a 12-year experience. Ann Surg (2011) 0.82
Portal stenting for hepatocellular carcinoma extending into the portal vein in cirrhotic patients. J Surg Oncol (2012) 0.81
Short- and long-term results of extended left hepatectomy for colorectal metastases. HPB (Oxford) (2011) 0.81
Investigation in liver tissues and cell lines of the transcription of 13 genes mapping to the 16q24 region that are frequently deleted in hepatocellular carcinoma. Clin Cancer Res (2002) 0.81
Percutaneous isolated hepatic perfusion for chemotherapy: a phase 1 study. Arch Surg (2003) 0.80
Analysis of chromosomal instability in pulmonary or liver metastases and matched primary hepatocellular carcinoma after orthotopic liver transplantation. Int J Cancer (2003) 0.80
Is primary resection and salvage transplantation for hepatocellular carcinoma a reasonable strategy? Ann Surg (2005) 0.80
Liver retransplantation: a model for determining long-term survival. Transplantation (2006) 0.80
Long-term results of combined liver-kidney transplantation for primary hyperoxaluria type 1: the French experience. Liver Transpl (2014) 0.80
Multivisceral transplantation for diffuse portomesenteric thrombosis. Ann Surg (2015) 0.80
Surgical management of congenital intrahepatic bile duct dilatation, Caroli's disease and syndrome: long-term results of the French Association of Surgery Multicenter Study. Ann Surg (2013) 0.80
Laparoscopic versus open gastric wedge resection for primary gastrointestinal tumors: clinical outcomes and health care costs analysis. Surg Laparosc Endosc Percutan Tech (2015) 0.79
Generation and modulation of hepatocellular carcinoma circulating cells: a new experimental model. J Surg Res (2008) 0.79
A decision analysis model identifies the interval of efficacy for transarterial chemoembolization (TACE) in cirrhotic patients with hepatocellular carcinoma awaiting liver transplantation. J Gastrointest Surg (2007) 0.79
Tumor marker evolution: comparison with imaging for assessment of response to chemotherapy in patients with colorectal liver metastases. Ann Surg Oncol (2010) 0.79
Microsatellite instability mutator phenotype in hepatocellular carcinoma in non-alcoholic and non-virally infected normal livers. Carcinogenesis (2003) 0.79
Histologic findings predictive of a diagnosis of de novo autoimmune hepatitis after liver transplantation in adults. Transplantation (2013) 0.79
Medical community preferences concerning adult living related donor liver transplantation. Gastroenterol Clin Biol (2006) 0.78
Closure of a home hospital program: impact on hospitalization rates. Arch Gerontol Geriatr (2006) 0.78
Increasing opioid therapy and survival in a hospice. J Am Geriatr Soc (2008) 0.78